Stock HNSBF HANSA BIOPHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Hansa Biopharma AB OTC Markets

Equities

HNSBF

SE0002148817

Delayed OTC Markets
Other stock markets
 09:30:14 2024-03-14 EDT 		5-day change 1st Jan Change
2.93 USD -9.98% Intraday chart for Hansa Biopharma AB -.--% +29.82%
06-27 Hansa Biopharma AB Announces Board Appointments CI
05-31 Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MODERNA, INC. Stock Moderna, Inc.
 47.96B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.45B
LONZA GROUP AG Stock Lonza Group AG
 41.47B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.6B -
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 28.63B
  1. Stock Market
  2. Equities
  3. HNSA Stock
  4. HNSBF Stock
  5. Charts Hansa Biopharma AB
  6. Sector Chart